跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tamzenef - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tamzenef
Approved
STANDARD
Tamzenef
General Pharmaceuticals Ltd. (Unit I)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1106d0a264709e9f
Company
General Pharmaceuticals Ltd. (Unit I)
Type
Standard
Approval Details
Approval Id
1106d0a264709e9f
Drug Approval Philippines Name
Tamzenef
Product Name
Tamzenef
Registration Number
DRP-6772-01
Brand Name
Tamzenef
Generic Name
Tamoxifen (As Citrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg
Manufacturer
General Pharmaceuticals Ltd. (Unit I)
Importer
Ambica International Corporation :
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
26 May 2021
Expiry Date
27 July 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1106d0a264709e9f
Type
Standard
Back to Philippines FDA Approvals